Dear Spiral User, we appreciate your patience during this upgrade which is to benefit our userbase, improve their experience in Spiral, introduce improvements, fixes and maintaining our versioning for future updates. Please note if you encounter any issues in Spiral, please raise a ticket to Research Applications team providing as much detail as possible in order to help us resolve your query. Again, we thank you for your patience and support during the upgrade. Kind Regards, Spiral Upgrade Team.
 
Infliximab and tofacitinib attenuate neutralizing antibody responses against SARS-CoV-2 ancestral and Omicron variants in IBD patients following 3 doses of COVID-19 vaccine
File(s)
Author(s)
Liu, Zhigang
Alexander, James
LIN, Kathy
Pollock, Katrina
Powell, Nick
Type
Journal Article
Date Issued
2023-02
Date Acceptance
2022-10-12
Citation
Gastroenterology, 2023, 164 (2), pp.300-303.e3
URI
URL
DOI
ISSN
0016-5085
Publisher
Elsevier
Start Page
300
End Page
303.e3
Journal / Book Title
Gastroenterology
Volume
164
Issue
2
Copyright Statement
© 2023 The Author(s). Published by Elsevier Inc. on behalf of the AGA
Institute. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
License URL
Identifier
https://www.sciencedirect.com/science/article/pii/S0016508522011842?via%3Dihub
Publication Status
Published
Date Publish Online
2022-10-19